The Current and Future of Biomarkers of Immune Related Adverse Events
Immunology and Allergy Clinics of North America · 2025
DOI: 10.1016/j.iac.2025.01.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2025. Verfasst von William Bracamonte-Baran und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Allergy & Immunology, Yale University, 300 Cedar Street, TAC S541, New Haven, CT 06520, USA. Hauptthemen laut MEDLINE: Biomarkers, Immune Checkpoint Inhibitors, Neoplasms, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 140 Literaturangaben. Gefördert von: NIAMS NIH HHS, National Institutes of Health, Rheumatology Research Foundation.
Themen: Patientensicherheit
Abstract (Originalsprache)
With their groundbreaking clinical responses, immune checkpoint inhibitors (ICIs) have ushered in a new chapter in cancer therapeutics. However, they are often associated with life-threatening or organ-threatening autoimmune/autoinflammatory phenomena, collectively termed immune-related adverse events (irAEs). In this review, we will first describe the mechanisms of action of ICIs as well as irAEs. Next, we will review biomarkers for predicting the development of irAEs or stratifying risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Allergy & Immunology, Yale University, 300 Cedar Street, TAC S541, New Haven, CT 06520, USA.
- Department of Rheumatology, Allergy & Immunology, Yale University, 300 Cedar Street, TAC S541, New Haven, CT 06520, USA. Electronic address: sangtaek.kim@yale.edu.
Förderung
- NIAMS NIH HHS
- National Institutes of Health
- Rheumatology Research Foundation
Zitieren
APA
Bracamonte-Baran, W., & Kim, S. T. (2025). The Current and Future of Biomarkers of Immune Related Adverse Events. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2025.01.010
Vancouver
Bracamonte-Baran W, Kim ST. The Current and Future of Biomarkers of Immune Related Adverse Events. Immunology and Allergy Clinics of North America. 2025. doi:10.1016/j.iac.2025.01.010
BibTeX
@article{BracamonteBaran2025,
author = {Bracamonte-Baran, William and Kim, Sang T},
title = {The Current and Future of Biomarkers of Immune Related Adverse Events},
journal = {Immunology and Allergy Clinics of North America},
year = {2025},
doi = {10.1016/j.iac.2025.01.010}
}
EUVIMED